MEDLAB 2018 Provides A Platform For The Interaction Between Clinical And Laboratory Path In The Middle East

Delegates at the MEDLAB Exhibition & Congress, the world’s leading event for laboratory management and diagnostics, which continues until 8^th February at the Dubai International Convention & Exhibition Centre, today engaged in the array of CME accredited conferences. A special emphasis was placed on Cardiology, Endocrinology, Tumour Markers and Clinical Microbiology. Attendees also had the opportunity to join leading companies, including Accelerate Diagnostics and National Reference Laboratory, for their workshops to hear first-hand about the latest medical laboratory innovations.

Clinical conferences continued to address today’s key healthcare issues. Cardiovascular disease has been the centre of attention in the healthcare sector for several years now as it is the leading cause of death globally. In addition, the complexity of cardiovascular diseases presents cardiology professionals with a myriad of challenges when considering disease prevention, evaluation and treatment. Opened by Professor Alawi Alsheikh-Ali, Dean – College of Medicine, Professor of Cardiovascular Medicine, Mohammed Bin Rashid, University of Medicine and Health Sciences, the Cardiology Conference provided an engaging opportunity for cardiovascular specialists to expand their knowledge and enhance their expertise. MEDLAB offered global and regional field leaders an opportunity to present a comprehensive review of new guidelines in the prevention and management of the disease and share contemporary and novel clinical techniques and strategies.

As most endocrine diseases are considered chronic disorders requiring life-long diagnostic testing to monitor and manage the disease, the medical specialty of endocrinology is more dependent on laboratory testing than any other specialty. New to MEDLAB for 2018, the Endocrinology Conference, a must-attend for everyone involved in the diagnoses and development of endocrine disorders, provided an interactive interpretation of complex endocrine disorders relevant for both specialists and non-specialists. Opening the conference, Dr Mario Skugor, Department of Endocrinology, Diabetes and Metabolism, Cleveland Clinic stated: “Clinical path and laboratory path should interact more. In my experience, many clinicians don’t know the basics of laboratory medicine, so exchange of knowledge between these two groups of healthcare professionals can only bring benefits to clinical outcomes. MEDLAB has recognised this need and it is on the right path to address this issue, but we all need to do more.”